학술논문

Continued indinavir (800 mg tid) versus switching to indinavir plus ritonavir (800/100 mg bid) in HIV patients having achieved viral load suppression. A randomized study: the BID efficacy and safety trial (BEST)
Document Type
Journal
Source
AIDS; OCT 2000, 14 pS8-pS8, 1p. Supplement: 4
Subject
Language
English
ISSN
02699370